Zhongkang holdings opens the offering: it plans to raise HK $395million net, and it is expected to be listed on July 12

6 month 28 Japan , Zhongkang Holdings （HK:02361） The announcement on the Hong Kong Stock Exchange said , In its 2022 year 6 month 28 solstice 7 month 5 Daily offering , To issue 7500 Ten thousand shares , Among them, Hong Kong sales account for 10%, International sales account for 90%, Attached 15% Over allotment .

According to the introduction , The offering price of Zhongkang holdings in this listing is... Per share 5.36 The Hong Kong dollar -6.96 The Hong Kong dollar , Every hand 500 stocks , It is expected that 2022 year 7 month 12 Japan is starting trading on the Hong Kong stock exchange . At the median issue price （6.16 The Hong Kong dollar ） Calculation , Zhongkang holdings plans to raise funds 4.62 Million Hong Kong dollars , The net amount raised is 3.95 Million Hong Kong dollars .

This listing , Zhongkang holdings also introduced 4 A cornerstone investor , A total subscription of 1.3 Million Hong Kong dollars . among , Qingdao Baiyang （SH:301015） subscription 2970 Million Hong Kong dollars 、Lun’s Family subscription 198 Thousands of dollars 、 Kangshi No. 1 limited partnership subscribes 3300 RMB 10,000 yuan 、 Zhengjingjie subscribes 4000 RMB 10,000 yuan .

According to BeiDuo finance and Economics , The full name of Zhongkang holdings is Zhongkang Holdings Co., Ltd （ Formerly known as “ Zhongkang Technology Holding Co., Ltd ”）, The main business entities in China are Guangzhou Zhongkang Information Co., Ltd. and its subsidiaries , Including Beijing Zhongkang Junyi Digital Technology Co., Ltd 、 Guangzhou Zhongkang Digital Technology Co., Ltd .

The prospectus shows , Zhongkang holdings mainly provides health insight solutions , To meet the sales and marketing needs of medical product manufacturers . These solutions are mainly based on the company's retail data , Retail data accounts for the majority of its health big data . Zhongkang holding believes that , The company is in a leading position in the medical products and channel segment .

According to iResearch Consulting Report , Just 2021 The revenue generated by medical products and channel health big data solutions in , Zhongkang holdings ranks first in China ; Just 2020 The number of top medical product manufacturers served by Chinese medical product and channel health insight solution providers in , Zhongkang holdings also ranks first in China .

The prospectus shows , By 2019 year 、2020 Years and 2021 year 12 month 31 End of day year , Zhongkang holdings realized revenue respectively 1.77 One hundred million yuan 、2.02 Million dollars 3.24 One hundred million yuan , Profit in the year （ Net profit ） Respectively 5437.9 Ten thousand yuan 、6932.9 Million and $ 7197.8 Ten thousand yuan .

As a whole , The income and profit scale of Zhongkang holdings have maintained a growth trend , among 2021 The year-on-year growth of revenue in has reached 60.4%, and 2020 The annual growth rate is 13.5%. meanwhile , Zhongkang Holdings 2020 year 、2021 The growth rate of net profit in was 20.1%、10.2%.

Under non HKFRS measurement , Zhongkang Holdings 2019 year 、2020 Years and 2021 The adjusted net profit for the year was 5437.9 Ten thousand yuan 、6932.9 Million and $ 9262.8 Ten thousand yuan , The corresponding adjusted net interest rates are 30.6%、32.3% and 28.6%.

By contrast , The net profit growth of Zhongkang holdings is still at a high level , among 2021 Year on year growth in adjusted net profit 33.6%. But Bedouin found that , The gross profit margin of Zhongkang holdings is not stable , among 2019 year 、2020 Years and 2021 The annual gross profit rates are 59.7%、64.4% and 59.4%, From high to low .

Zhongkang Holdings said in the prospectus , It has developed a wide customer base . By 2019 year 、2020 Years and 2021 Year ended , The company owns 630 name 、702 Name and 918 Enterprise customers . According to iResearch Consulting Report , On 2021 year , Among them is 63 Top medical product manufacturer customers （69.8%）, Trading with the company for three consecutive years .

During the reporting period , The cooperative drugstore of Zhongkang holdings is owned by 2019 Year of 496 Home is increased to 1072 home , The retail pharmacies covered are 2019 Year of 25157 Home is increased to 2021 Year of 52882 home , among 55.7% For chain drugstores . Zhongkang holding said , The cooperative pharmacy network has laid the foundation for the improvement of data capability .

During the reporting period , The revenues of Zhongkang holding from its customers of medical product manufacturers are 1.65 One hundred million yuan 、1.85 Million dollars 2.92 One hundred million yuan , The proportion in the total income of the same period is 93.0%、91.8% And 90.0%. According to iResearch Consulting Report , The health insight solution market for China's medical products and channels is 2016 - 2021 In the past years 50.9% Compound annual growth rate of .

By 2019 year 、2020 Years and 2021 year 12 month 31 End of day year , The data collection costs of Zhongkang holdings are about 200 Ten thousand yuan 、350 Wan Yuan and 630 Ten thousand yuan , Respectively accounting for about... Of the data cost in the same period 66.7%、73.6% And 70.6% And the total cost of sales is about 2.8%、4.9% And 4.8%.